ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

MJH Life Sciences™ Announces Long-Term Partnership with BDT Capital Partners

November 16, 2021 GMT

CRANBURY, N.J.--(BUSINESS WIRE)--Nov 16, 2021--

MJH Life Sciences™ (“the Company”) is excited to announce today that BDT Capital Partners, LLC (“BDT”), affiliated with BDT & Company, LLC, a merchant bank that provides closely held businesses with long-term, differentiated capital, has agreed to acquire a majority interest in the Company through its affiliated funds.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116006137/en/

Together, the MJH Life Sciences™ team and BDT will continue the strong growth trajectory of the Company, while staying true to the Company’s mission of providing healthcare professionals with the high-quality trusted information, resources, and education they need to make mission critical patient care decisions. BDT is thrilled to work alongside current CEO, Michael Hennessy Jr., as well as the tenured leadership team, to position the Company for long-term growth and success.

ADVERTISEMENT

New Partnership Positions MJH Life Sciences™ for Long-term Growth

“MJH Life Sciences™ has experienced robust growth over its 20+ year history, fueled by the acceleration in biotech funding, a healthy pharma pipeline, and growth in new drug approvals. All these factors have supported strong demand for MJH Life Sciences™ to connect large pharma and biotech companies with healthcare professionals around the United States,” said MJH Life Sciences™ CEO Mike Hennessy Jr. “In order to continue to enhance overall engagement between healthcare professionals and pharma, we’ve sought a long-term capital partner to continue to grow our audience reach, and ensure we will continue to provide best-in-class service to our clients well into the future. We have purposefully and diligently selected a partner in BDT who honors our values and competitive spirit, while also demonstrating the ability to support our vision and add meaningful strategic value.”

“MJH Life Sciences™ is home to some of the world’s most iconic healthcare content brands across oncology, primary care, specialty care, pharmacy, industry sciences, and more. We are incredibly excited to partner with the Hennessy family and Mike’s experienced leadership team as they look to further expand the business in both existing and emerging categories,” said Tiffany Hagge, Partner and COO of BDT Capital Partners’ Investment Committee. “This investment is core to what we do, exemplifying BDT’s commitment to partner and invest alongside exceptional family businesses with strong cultures, talented employees, loyal customers, and in the case of MJH, providing a mission critical service to the healthcare community.”

ADVERTISEMENT

Bank of America Merrill Lynch acted as transaction advisor and Day Pitney acted as legal advisor to MJH Life Sciences™. Davis Polk & Wardwell acted as legal advisor to BDT Capital Partners. Bank of America Merrill Lynch and PNC Bank will provide the committed financing to support the transaction. Closing of the transaction is expected later this year and is subject to customary regulatory and other conditions. Additional terms were not disclosed.

About MJH Life Sciences™

MJH Life Sciences™ is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit https://www.mjhlifesciences.com/.

About BDT Capital Partners

BDT Capital Partners provides family- and founder-led businesses with long-term, differentiated capital. The firm has raised $18 billion across its investment funds and its global investor base has invested an additional $10 billion of debt and equity in the funds’ portfolio companies. The firm’s affiliate, BDT & Company, is a merchant bank that works with family- and founder-led businesses to pursue their strategic and financial objectives. BDT & Company provides solutions-based advice and access to a world-class network of business owners and leaders.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211116006137/en/

CONTACT: Media:

MJH Life Sciences™

Alyssa Scarpaci

609-716-7777

ascarpaci@mjhlifesciences.comBDT Capital Partners

Sara Evans

212-508-8661

sevans@bdtcap.com

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: FINANCE HOSPITALS BANKING PROFESSIONAL SERVICES PRACTICE MANAGEMENT MANAGED CARE HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: BDT Capital Partners, LLC

Copyright Business Wire 2021.

PUB: 11/16/2021 12:00 PM/DISC: 11/16/2021 12:01 PM

http://www.businesswire.com/news/home/20211116006137/en